UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Annals of oncology, 2017-06, Vol.28 (6), p.1339-1345

2017

Volltextzugriff (PDF)

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4)

Annals of oncology, 2016-03, Vol.27 (3), p.441-448

2016

Volltextzugriff (PDF)

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Annals of oncology, 2018-11, Vol.29 (11), p.2269-2269

2018

Volltextzugriff (PDF)

2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis

European journal of cancer (1990), 2015-09, Vol.51, p.S524-S524

2015

Volltextzugriff (PDF)

2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis

European journal of cancer (1990), 2015-09, Vol.51, p.S518-S519

2015

Volltextzugriff (PDF)

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC)

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S37-S37

2014

Volltextzugriff (PDF)

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821)

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S37-S38

2014

Volltextzugriff (PDF)

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer

Annals of oncology, 2006-03, Vol.17 (3), p.437-442

2006

Volltextzugriff (PDF)

Abstract CT129: Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in NSCLC involving the CNS

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT129-CT129

2016

Volltextzugriff (PDF)

Hemorrhagic fever virus-induced changes in hemostasis and vascular biology

Blood coagulation & fibrinolysis, 2000-07, Vol.11 (5), p.461-483

2000

Volltextzugriff (PDF)

Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome

The Journal of infectious diseases, 1991-12, Vol.164 (6), p.1119-1127

1991

Volltextzugriff (PDF)

Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Annals of oncology, 2018-11, Vol.29 (11), p.2269-2269

2018

Volltextzugriff (PDF)

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

The New England journal of medicine, 2016-08, Vol.375 (8), p.754-766

2016

Volltextzugriff (PDF)

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

Antiviral research, 2009-01, Vol.81 (1), p.68-76

2009

Volltextzugriff (PDF)

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1688-1700

2017

Volltextzugriff (PDF)

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC): Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S37-S37

2014

Volltextzugriff (PDF)

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

The lancet oncology, 2015-02, Vol.16 (2), p.152-160

2015

Volltextzugriff (PDF)

Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin

American Journal of Hematology, 1998-01, Vol.57 (1), p.85-86

1998

Volltextzugriff (PDF)

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821): Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S37-S38

2014

Volltextzugriff (PDF)

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

The New England journal of medicine, 2013-01, Vol.368 (2), p.138-148

2013

Volltextzugriff (PDF)

Pulmonary Edema in Falciparum Malaria: Slaying the Dragon of Volume Overload

Chest, 1990-07, Vol.98 (1), p.10-13

Cosgriff, Thomas M.

1990

Volltextzugriff (PDF)

Abiraterone and Increased Survival in Metastatic Prostate Cancer

The New England journal of medicine, 2011-05, Vol.364 (21), p.1995-2005

2011

Volltextzugriff (PDF)

Pathogenesis of Rift Valley fever in rhesus monkeys : role of interferon response

Archives of virology, 1990-01, Vol.110 (3-4), p.195-212

1990

Volltextzugriff (PDF)

Mechanisms of disease in hemorrhagic fever with renal syndrome

Kidney international. Supplement, 1991-12, Vol.35, p.S72

1991

Volltextzugriff (PDF)

1 – 25 von 773

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(605)
Mit Volltextzugriff
(606)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(772)

Erscheinungsjahr

n.n

Thema

Science & Technology
(383)
Life Sciences & Biomedicine
(252)
Humans
(199)
Technology
(120)
Biological And Medical Sciences
(89)
Materials Science
(84)
Medical Sciences
(78)
Male
(77)
Female
(68)
Engineering
(67)
Adult
(64)
Animals
(54)
Engineering, Biomedical
(50)
Materials Science, Biomaterials
(49)
General & Internal Medicine
(44)
Middle Aged
(42)
Physical Sciences
(41)
Medicine, General & Internal
(37)
Aged
(32)
Radiology, Nuclear Medicine & Medical Imaging
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4)

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis

2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC)

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821)

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer

Abstract CT129: Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in NSCLC involving the CNS

Hemorrhagic fever virus-induced changes in hemostasis and vascular biology

Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome

Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC): Metastatic Non-Small Cell Lung Cancer

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821): Metastatic Non-Small Cell Lung Cancer

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Pulmonary Edema in Falciparum Malaria: Slaying the Dragon of Volume Overload

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Pathogenesis of Rift Valley fever in rhesus monkeys : role of interferon response

Mechanisms of disease in hemorrhagic fever with renal syndrome

Suchergebnisse filtern